Ambu ruled out raising capital in August – now it's "due diligence"

One analyst says the Danish medtech company’s goal to lower its gearing would have happened naturally over time.
Ambu leadership, including CFO Thomas Schmidt (left), CEO Britt Meelby Jensen, and CMO Bassel Rifai, announced plans to raise capital during the company's capital markets day on Tuesday | Photo: Ulrich Fischer Skov Quistgaard
Ambu leadership, including CFO Thomas Schmidt (left), CEO Britt Meelby Jensen, and CMO Bassel Rifai, announced plans to raise capital during the company's capital markets day on Tuesday | Photo: Ulrich Fischer Skov Quistgaard
by ulrich quistgaard, translated by daniel pedersen

In summer of last year, Ambu leadership outright rejected that the company would have a need to raise more capital – now it is planning to issue shares for over DKK 1bn (USD 145m). 

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading